Terms: = Gastric cancer AND SPOP, TEF2, 8405, ENSG00000121067, O43791
7 results:
1. Deficiency in spop-mediated ubiquitination and degradation of TIAM1 promotes gastric cancer progression.
Liu F; Zhang T; Sun X; Liu Z; Xu W; Dai X; Zhang X
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167032. PubMed ID: 38246227
[TBL] [Abstract] [Full Text] [Related]
2. rs2671655 single nucleotide polymorphism modulates the risk for gastric cancer in Helicobacter pylori-infected individuals: a genome-wide association study in the Korean population.
Shin CM; Park K; Kim N; Won S; Ohn JH; Lee S; Park JH; Kang SJ; Kim JS; Lee DH
Gastric Cancer; 2022 May; 25(3):573-585. PubMed ID: 35325318
[TBL] [Abstract] [Full Text] [Related]
3. LncRNA ADAMTS9-AS2 suppresses the proliferation of gastric cancer cells and the tumorigenicity of cancer stem cells through regulating spop.
Wang F; Tang C; Xu D; Tang Y; Jiang Y; Gao X; Xu J
J Cell Mol Med; 2020 Apr; 24(8):4830-4838. PubMed ID: 32160650
[TBL] [Abstract] [Full Text] [Related]
4. The emerging role of spop protein in tumorigenesis and cancer therapy.
Song Y; Xu Y; Pan C; Yan L; Wang ZW; Zhu X
Mol Cancer; 2020 Jan; 19(1):2. PubMed ID: 31901237
[TBL] [Abstract] [Full Text] [Related]
5. Relationship between spop mutation and breast cancer in Chinese population.
Khan MA; Zhu L; Tania M; Xiao XL; Fu JJ
Genet Mol Res; 2015 Oct; 14(4):12362-6. PubMed ID: 26505385
[TBL] [Abstract] [Full Text] [Related]
6. spop suppresses tumorigenesis by regulating Hedgehog/Gli2 signaling pathway in gastric cancer.
Zeng C; Wang Y; Lu Q; Chen J; Zhang J; Liu T; Lv N; Luo S
J Exp Clin Cancer Res; 2014 Sep; 33(1):75. PubMed ID: 25204354
[TBL] [Abstract] [Full Text] [Related]
7. Mutational and expressional analyses of spop, a candidate tumor suppressor gene, in prostate, gastric and colorectal cancers.
Kim MS; Je EM; Oh JE; Yoo NJ; Lee SH
APMIS; 2013 Jul; 121(7):626-33. PubMed ID: 23216165
[TBL] [Abstract] [Full Text] [Related]
